Navigation Links
Dr. Fred Ueland, Markey Cancer Center, University of Kentucky Presents OVA1™ High Sensitivity Data at the 13th Annual International Gynecologic Cancer Society Meeting
Date:10/25/2010

AUSTIN, Texas, Oct. 25 /PRNewswire-FirstCall/ -- (Nasdaq: VRML) -- Fred Ueland, M.D., Associate Professor of Gynecologic Oncology at the University of Kentucky's Markey Cancer Center, and principal investigator of the multi-center OVA1™ clinical trial, today presented data demonstrating the high sensitivity of the OVA1 test at the 13th Annual International Gynecologic Cancer Society Meeting being held in Prague, October 23-26.

Dr. Ueland's presentation demonstrated that OVA1 had sensitivity for ovarian cancer of 92.5%, as compared to 68.9% for CA125 using cutoffs established in the ACOG criteria for adnexal mass evaluation and 77.0% for CA125 using cutoffs in the modified ACOG criteria.  Additionally, OVA1 detected 23/24 stage I epithelial ovarian cancers (EOC) and 17/17 stage II epithelial ovarian cancer, for an overall sensitivity of 97.6% for early stage EOC, as compared to 65.9% for CA125 using the ACOG cutoffs. The improvement in sensitivity was even greater among premenopausal women; for OVA1, sensitivity for early stage EOC was 92.9% and for CA125, sensitivity was 35.7%. Overall, OVA1 detected 76% of malignancies missed by CA125, including all advanced stage malignancies.

"Studies show that women have more favorable outcomes when surgery for ovarian cancer is performed by a gynecologic oncologist," explained Dr. Ueland. "The current research further demonstrates that OVA1 will not only help identify more women with ovarian cancer for referral, but can give them greater confidence that their ovarian tumor is benign."

"Because of the high mortality from ovarian cancer, clinical sensitivity for malignancy is paramount," said Gail S. Page, Chair and Chief Executive Officer of Vermillion, Inc. "These data further support the clinical utility of OVA1 as an adjunctive tool to aid physicians in the assessment of women with an adnexal mass for whom surg
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Reportlinker Adds Triple Analysis: Lymphoma, Cancer Vaccines and Antibodies
2. Reportlinker Adds Breast Cancer Drug Futures
3. Clinicians Use Advanced Radiotherapy Imaging Techniques from Elekta to More Accurately Visualize Moving Tumors in Patients with Lung Cancer
4. Northwest Biotherapeutics to Present at Inaugural Cancer Immunotherapy Conference
5. LCS Constructors, Inc. Supports the Cure and Breast Cancer Awareness Month
6. European Nurse Society Calls to Action on Breakthrough Cancer Pain
7. Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology
8. TEVA AND ONCOGENEX ANNOUNCE INITIATION OF SECOND PHASE 3 TRIAL OF CUSTIRSEN IN MEN WITH METASTATIC PROSTATE CANCER
9. Clarisonic Empowers Cancer Patients to Put Their Best Face Forward
10. Leading Journal Turns Up the Heat on Cutting-Edge Breast Cancer Treatment
11. Reportlinker Adds Cancer Profiling and Pathways: Technologies and Global Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... The Fertility Centers of New England ... Vitiello has taken on a new and expanded role ... provide guidance, leadership, oversight and quality assurance for the ... among our team of experienced reproductive endocrinologists,” said Fertility ... Hill, M.D. “Her expertise and compassionate, individualized care have ...
(Date:5/28/2015)... Dr. Carl Peck, MD, Chairman of ... Williams, MD, has joined the firm as a ... top tier consultants whose expertise and professional stature ... company’s clients. Premier Experts collaborate to design and ... their medical products, pursue optimal regulatory pathways, build ...
(Date:5/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/l633xp/molecular ... PharmaBiotech,s new report "Molecular Diagnostics - ... offering. This report describes and ... play an important role in practice of ... biological warfare in the 21st century. This ...
(Date:5/27/2015)... , May 27, 2015  Tikcro Technologies Ltd. (OTCQB: ... March 31, 2015. Aviv Boim ... continued pre-clinical work to generate functional specific antibodies, targeting ... stage, we are encouraged by the development progress. We ... new antibodies which modulate immune checkpoints gain clinical acceptance ...
Breaking Biology Technology:Danielle Vitiello, MD of Fertility Centers of New England, Named New Medical Director 2Former CEO and Chair of the Council of Experts at the USP, Roger L. Williams, MD, Joins NDA Partners as a Premier Expert Consultant 2Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 2Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 3Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3
... Wound Management Technologies, Inc., (OTC Bulletin Board: ... announced today that its President, Deborah Jenkins Hutchinson, will ... CellerateRX®, recent strategic developments, and its product pipeline at ... held at the JW Marriott Marquis Miami on November ...
... Accuray Incorporated (Nasdaq: ARAY ), a global ... management is scheduled to present at the Lazard Capital Markets, ... 2010 at 10:30 a.m. ET/7:30 a.m. PT. A ... the Investor Relations page of the Company,s Web site at ...
... , University of California, Berkeley, scientists have found a way ... the poor resolution of the picture. Everyone who ... with the impressionistic nature of the images. One of the ... of the sound: The basic laws of physics dictate that ...
Cached Biology Technology:Wound Management Technologies to Present at LifeTech Capital Miami Medical Investors Conference 2Accuray Incorporated to Speak at Seventh Annual Lazard Capital Markets' Healthcare Conference 2Novel metamaterial vastly improves quality of ultrasound imaging 2
(Date:4/27/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... the first week of May, 2015 and will be ... Gino Pereira , Chief Executive ... company as Wocket® enters the consumer market. We would ...
(Date:4/21/2015)... , April 21, 2015 ... evolving government policies are boosting access control systems market ... According to a recently published report by TechSci ... 2020 ", the access control systems market in ... USD1.2 billion by 2020.The access control systems market in ...
(Date:4/20/2015)... , April 20, 2015 The ... Glenbeigh Records Management (GRM), Ireland,s ... Dubai Islamic Bank. Having built up an impressive track record ... a leading player within the records management sector in ... to double is GCC staffbase and employ a further eight ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... co-operation with a research group from Singapore, scientists at ... in the form of truncated O-glycans aid growth properties ... to decode the significance of these truncated O-glycans, and ... journal PNAS , represent an important contribution to ...
... our brains how full we are becomes damaged in obese people ... to new research from the University of Adelaide . ... who lose weight on a diet eventually put that weight back ... Kentish investigated the impact of a high-fat diet on the gut,s ...
... YORK , Sept. 16, 2013 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Dry Eye Syndrome - India ...
Cached Biology News:Specific sugar molecule causes growth of cancer cells 2Obese stomachs tell us diets are doomed to fail 2PharmaPoint: Dry Eye Syndrome - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Dry Eye Syndrome - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Dry Eye Syndrome - India Drug Forecast and Market Analysis to 2022 4
Vented Caps for 75 cm2 Flasks...
BD BioCoat Poly-D-Lysine 60 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of poly-D-lysine....
BD BioCoat Laminin 60 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse laminin....
... Series 4000 incorporates the critical design features ... in biomarker research. The Series 4000 delivers ... converting biomarker discoveries to biomarker assays all ... is designed to fit into the research ...
Biology Products: